Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Gallery Posts

Day: April 3, 2025

Checkpoint inhibitor therapy (CIT) is a form of cancer immunotherapy that targets immune checkpoints, key regulators of the immune system. By blocking these checkpoints, CIT enhances the immune response against cancer cells, offering a promising approach for various malignancies. Below is a detailed overview of its mechanisms, clinical applications, and challenges, supported by current evidence.

Checkpoint Inhibitor Therapy (CIT)

Checkpoint inhibitor therapy (CIT) is a form of cancer immunotherapy that targets immune checkpoints, key regulators of the immune system. By blocking these checkpoints, CIT enhances the immune response against cancer

Read More
Oncolytic virus therapy (OVT) is a promising cancer treatment that leverages viruses to selectively infect and destroy tumor cells while stimulating an antitumor immune response. Below is a detailed overview of its mechanisms, clinical applications, and challenges, supported by current evidence.

Oncolytic Virus Therapy (OVT)

Oncolytic virus therapy (OVT) is a promising cancer treatment that leverages viruses to selectively infect and destroy tumor cells while stimulating an antitumor immune response. Below is a detailed overview of

Read More
Cytokine-Induced Killer (CIK) Cell Therapy are heterogeneous immune effector cells with hybrid T-cell and natural killer (NK) cell properties. Generated ex vivo from peripheral or cord blood mononuclear cells using cytokines (interferon-γ, IL-2, anti-CD3 antibody), they exhibit potent MHC-unrestricted cytotoxicity against tumors. Below is a synthesis of their mechanisms, clinical utility, and challenges.

Cytokine-Induced Killer (CIK) Cell Therapy

Cytokine-Induced Killer (CIK) Cell Therapy are heterogeneous immune effector cells with hybrid T-cell and natural killer (NK) cell properties. Generated ex vivo from peripheral or cord blood mononuclear cells using cytokines

Read More
Tumor Mutational Burden (TMB) quantifies the number of non-inherited somatic mutations per megabase (Mb) of tumor DNA. It serves as a predictive and prognostic biomarker in oncology, particularly for immunotherapy response. Below is a synthesis of its key aspects, supported by current evidence.

Tumor Mutational Burden (TMB)

Tumor Mutational Burden (TMB) quantifies the number of non-inherited somatic mutations per megabase (Mb) of tumor DNA. It serves as a predictive and prognostic biomarker in oncology, particularly for immunotherapy response.

Read More